These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19643446)

  • 1. Anti-endothelial serum antibodies in a patient with Susac's syndrome.
    Jarius S; Neumayer B; Wandinger KP; Hartmann M; Wildemann B
    J Neurol Sci; 2009 Oct; 285(1-2):259-61. PubMed ID: 19643446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susac's syndrome, a rare, potentially severe or lethal neurological disease.
    Saux A; Niango G; Charif M; Morales R; Mura F; Bonafe A; Mourand I
    J Neurol Sci; 2010 Oct; 297(1-2):71-3. PubMed ID: 20723912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Susac's syndrome.
    Rennebohm RM; Susac JO
    J Neurol Sci; 2007 Jun; 257(1-2):215-20. PubMed ID: 17324441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin involvement in Susac's syndrome.
    Turc G; Monnet D; Dupin N; Beuvon F; Guiraud V; Ben Amor M; Touzé E
    J Neurol Sci; 2011 Jun; 305(1-2):152-5. PubMed ID: 21440909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susac's syndrome: 1975-2005 microangiopathy/autoimmune endotheliopathy.
    Susac JO; Egan RA; Rennebohm RM; Lubow M
    J Neurol Sci; 2007 Jun; 257(1-2):270-2. PubMed ID: 17331544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum antibodies against corneal and internal ear tissues in Cogan's syndrome].
    Arnold W; Gebbers JO
    Laryngol Rhinol Otol (Stuttg); 1984 Aug; 63(8):428-32. PubMed ID: 6384707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
    Takahashi T; Fujihara K; Nakashima I; Misu T; Miyazawa I; Nakamura M; Watanabe S; Shiga Y; Kanaoka C; Fujimori J; Sato S; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1235-43. PubMed ID: 17449477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrullinated antigens in RA.
    Engelmann R; Brandt J; Eggert M; Karberg K; Krause A; Neeck G; Mueller-Hilke B
    Rheumatology (Oxford); 2008 Oct; 47(10):1489-92. PubMed ID: 18703528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susac syndrome: an organ-specific autoimmune endotheliopathy syndrome associated with anti-endothelial cell antibodies.
    Magro CM; Poe JC; Lubow M; Susac JO
    Am J Clin Pathol; 2011 Dec; 136(6):903-12. PubMed ID: 22095376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunopathology of the inner ear].
    Arnold W; Altermatt HJ; Gebbers JO; Pfaltz CR
    Laryngol Rhinol Otol (Stuttg); 1985 Jan; 64(1):1-8. PubMed ID: 3881636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susac's Syndrome--update.
    Rennebohm R; Susac JO; Egan RA; Daroff RB
    J Neurol Sci; 2010 Dec; 299(1-2):86-91. PubMed ID: 20855088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first Susac's syndrome case in Turkey.
    Erer S; Boz M; Taskapilioglu O; Hakyemez B; Kaderli B; Zarifoglu M
    J Neurol Sci; 2006 Dec; 251(1-2):134-7. PubMed ID: 17109892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susac's syndrome during pregnancy - the first Croatian case.
    Antulov R; Holjar Erlic I; Perkovic O; Miletic D; Antoncic I
    J Neurol Sci; 2014 Jun; 341(1-2):162-4. PubMed ID: 24768309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Susac's syndrome: improvement with combined cyclophosphamide and intravenous immunoglobulin therapy].
    Papeix C; Laloum L; Richet A; Ayache D; Moulignier A; Héran F; Bakouche P; Gout O
    Rev Neurol (Paris); 2000 Sep; 156(8-9):783-5. PubMed ID: 10992124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susac's syndrome--pathogenesis, clinical variants and treatment approaches.
    Greco A; De Virgilio A; Gallo A; Fusconi M; Turchetta R; Tombolini M; Rizzo MI; de Vincentiis M
    Autoimmun Rev; 2014 Aug; 13(8):814-21. PubMed ID: 24727151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour necrosis factor (TNF) inhibitor therapy in Susac's syndrome.
    Hardy TA; Garsia RJ; Halmagyi GM; Lewis SJ; Harrisberg B; Fulham MJ; Barnett MH
    J Neurol Sci; 2011 Mar; 302(1-2):126-8. PubMed ID: 21167503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity.
    Schett G; Xu Q; Amberger A; Van der Zee R; Recheis H; Willeit J; Wick G
    J Clin Invest; 1995 Dec; 96(6):2569-77. PubMed ID: 8675620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cauda equina involvement in Susac's syndrome.
    Allmendinger AM; Mallery RM; Magro CM; Wang N; Egan RA; Samuels MA; Callahan A; Viswanadhan N; Klufas RA; Hsu L; Prasad S
    J Neurol Sci; 2014 Feb; 337(1-2):91-6. PubMed ID: 24290499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of anti-endothelial cell antibodies on the interactions of leukocytes with vascular endothelial cells in vitro.
    Elgebaly SA; Herkert N; Gillies CC; Picciano PT; Donaldson MC; Kreutzer DL
    J Exp Pathol; 1985; 2(1):59-73. PubMed ID: 3915999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predominance of IgG4 in prodromal bullous pemphigoid.
    Lamb PM; Patton T; Deng JS
    Int J Dermatol; 2008 Feb; 47(2):150-3. PubMed ID: 18211485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.